Patients who undergo peroral double-balloon enteroscopy
Conditions
Interventions
An intravenous drip injection of 150,000 U of ulinastatin dissolved in 100 ml of physiological saline for 2 hours from the start of peroral double-balloon enteroscopy
An intravenous drip injection of
Sponsors
Intmed3 DBE study group
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who undergo peroral double-balloon enteroscopy who are 20 years of age or older, are able to understand the concerned clinical study and give written informed consent.
Exclusion criteria
Exclusion criteria: (1) patients who have acute pancreatitis or chronic pancreatitis (2) patients with known hypersensitivity to ulinastatin (3) women who are pregnant or possible pregnant (4) patients taking endoscopy which is not aiming the insertion of endoscope deep into the small intestine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| serum pancreatic amylase level and serum lipase level 3 hours after and in the next morning of peroral double-balloon enteroscopy | — |
Secondary
| Measure | Time frame |
|---|---|
| presence or absence of pancreatitis after peroral double-balloon enteroscopy | — |
Countries
Japan
Contacts
Public ContactKazuhiko Nakamura
Kyushu University Department of Medicine and Bioregulatory Science
Outcome results
None listed